If you are a student, recent graduate or alumni interested in exploring a career in the biotechnology, pharmaceutical and life sciences industries, you are in the right place! Register today to start your job search and be contacted by employers nationwide looking for you! It only takes a few minutes and you will be on your way to the perfect job!
Feel the Difference of Working Here. The character of our environments radiates from Our Credo values.
Search Jobs...
Genzyme's people and culture have been consistently recognized for excellence. We have been named several times to Fortune's list of the "100 Best Companies to Work For" in the United States.
Search Jobs...
Biogen Idec Inc., a global biotechnology leader with leading products and capabilities in oncology, neurology and immunology, is committed to transforming scientific discovery...
Search Jobs...
RICHMOND — Virginia Gov. Bob McDonnell said Wednesday he is seeking nearly $37 million in his biennial budget to lure businesses and jobs to the commonwealth, putting much of the focus on life sciences and biotechnology — sectors that are staples of the economy of neighboring Maryland.
Full StoryTHE prospect of more jobs for Edinburgh and the Lothians in biosciences and renewable energy has been given a boost by the designation of three new enterprise zone sites.
Full StoryOn Jan. 11, over 240 Massachusetts high school students and teachers participated in Biotech Futures, including Norton’s own Marissa McCabe and Kaitlin Murrin.
Full StoryThe Biotech industry in the United States has witnessed a concern relating to high costs of drugs, which has prompted the medicine makers to look for biosimilar versions in the market. According to a new report “US Biotech Market Analysis” by RNCOS, the regulatory scenario in the country has been improving with respect to biosimilars. Efforts are being made to create a proper regulatory pathway for biosimilar approval. The future for this segment in the US biotech industry seems highly promising.
Full StoryHOUSTON, Jan 04, 2012 (BUSINESS WIRE)—Bio-Path Holdings, Inc. BPTH +4.00% ("Bio-Path"), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that Peter Nielsen, President and Chief Executive Officer, will present a company overview at the Biotech Showcase(TM) 2012 Conference in San Francisco, CA on Wednesday, January 11, 2012 at 3:30 p.m. Pacific Time.
Full StoryIn a time when jobs are hard to come by, the medical field is an exception.
Full StoryPRA International, a US based clinical research organization which conducts clinical trials across therapeutic areas and provides services in all clinical development phases, will be opening new offices in Israel and the Ukraine.
Full StoryPROPEL, a center of the iBIO Institute, was awarded a grant of $200,000 by the Searle Funds at The Chicago Community Trust in support of its programs to assist the development of small, seed-stage life sciences companies in Illinois.
Full StoryThere’s a lot of competition today for jobs in the biotech and pharmaceutical industries, and not all of it comes from other academic labs.
Full Story
Phoenix • Tucson • Palm Springs • Sacramento • San Diego • San Francisco • San Jose • Denver • Jacksonville • Miami • Orlando • Tampa • Atlanta • Chicago • Indianapolis • Kansas City • Louisville • New Orleans • Boston • Baltimore • Detroit • Grand Rapids • Minneapolis • Charlotte • Raleigh • Omaha • Atlantic City • Las Vegas • Reno • Buffalo • New York City • Cincinnati • Cleveland • Toledo • Tulsa • Portland • Philadelphia • Pittsburgh • Myrtle Beach • Memphis • Nashville • Austin • Dallas • Houston • San Antonio • Salt Lake City • Richmond • Seattle • Spokane
